Extra-axial brain tumors.
Rapalino O, Smirniotopoulos JG.
Handb Clin Neurol. 2016;135:275-291. doi: 10.1016/B978-0-444-53485-9.00015-5.
The epidemiology of glioma in adults: a "state of the science" review.
Ostrom QT, Bauchet L, Davis FG, Deltour I, Fisher JL, Langer CE, Pekmezci M, Schwartzbaum JA, Turner MC, Walsh KM, Wrensch MR, Barnholtz-Sloan JS.
Neuro Oncol. 2014 Jul;16(7):896-913. doi: 10.1093/neuonc/nou087.
Intracranial malignant triton tumor in a patient with neurofibromatosis type 1: case report and review of the literature.
Smith RE, Kebriaei MA, Gard AP, McComb RD, Bridge JA, Lennarson PJ.
Brain Tumor Pathol. 2014 Apr;31(2):149-54. doi: 10.1007/s10014-013-0147-z. Epub 2013 Apr 30.
Primary intracranial epithelioid hemangioendothelioma: a low-proliferation tumor exhibiting clinically malignant behavior.
Zheng J, Liu L, Wang J, Wang S, Cao Y, Zhao J.
J Neurooncol. 2012 Oct;110(1):119-27. doi: 10.1007/s11060-012-0945-x. Epub 2012 Aug 11.
Recurring intracranial malignant peripheral nerve sheath tumor: case report and systematic review of the literature.
van den Munckhof P, Germans MR, Schouten-van Meeteren AY, Oldenburger F, Troost D, Vandertop WP.
Neurosurgery. 2011 Apr;68(4):E1152-8; discussion E1159. doi: 10.1227/NEU.0b013e31820a1599.
Epidemiology and survival of primary intracranial malignant tumor patients with drop metastasis: a population-based analysis.
Jin Y, Lu T, Liu B, Wang Y.
Acta Neurochir (Wien). 2024 Oct 16;166(1):413. doi: 10.1007/s00701-024-06309-2.
Neuro-oncologic Emergencies.
Suarez-Meade P, Marenco-Hillembrand L, Sherman WJ.
Curr Oncol Rep. 2022 Aug;24(8):975-984. doi: 10.1007/s11912-022-01259-3. Epub 2022 Mar 30.
[Intracranial tumor].
Conter C, Frappaz D.
Rev Prat. 2008 Mar 15;58(5):565-70.
Microenvironmental regulation of tumor-associated neutrophils in malignant glioma: from mechanism to therapy.
Wen J, Liu D, Zhu H, Shu K.
J Neuroinflammation. 2024 Sep 16;21(1):226. doi: 10.1186/s12974-024-03222-4.
Malignant Intracranial High Grade Glioma and Current Treatment Strategy.
Zhang X, Zhang W, Mao XG, Cao WD, Zhen HN, Hu SJ.
Curr Cancer Drug Targets. 2019;19(2):101-108. doi: 10.2174/1568009618666180530090922.
